Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6111]

Epstein-Barr virus associated tumours and drug repurposing

Epstein-Barr virus associated tumours and drug repurposing

Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

Study identifies two promising molecular targets for drug development in recurrent and metastatic cervical cancer

Ribociclib and letrozole combination is active in patients with advanced or recurrent LGSOC

Ribociclib and letrozole combination is active in patients with advanced or recurrent LGSOC

The addition of gemcitabine with cisplatin and intensity-modulated radiation therapy improves outcomes for women with locally advanced vulvar cancer

The addition of gemcitabine with cisplatin and intensity-modulated radiation therapy improves outcomes for women...

A new, sustainable source for a promising cancer killer

A new, sustainable source for a promising cancer killer

Implementing cancer personalised medicine at national level

Implementing cancer personalised medicine at national level

FDA grants accelerated approval to retifanlimab-dlwr for metastatic or recurrent locally advanced Merkel cell carcinoma

FDA grants accelerated approval to retifanlimab-dlwr for metastatic or recurrent locally advanced Merkel cell...

Fat-burning molecule may be promising target for most common childhood brain cancer

Fat-burning molecule may be promising target for most common childhood brain cancer

Cell-penetrating protein targeting PCNA safely administered as IV infusion and shows clinical activity

Cell-penetrating protein targeting PCNA safely administered as IV infusion and shows clinical activity

Underlying molecular mechanism causing pancreatic cancer to metastasize and become fatal discovered

Underlying molecular mechanism causing pancreatic cancer to metastasize and become fatal discovered

More from ecancer